Pfizer Inc. (PFE)
27.78
-0.01
(-0.04%)
USD |
NYSE |
Sep 09, 16:00
27.81
+0.03
(+0.11%)
After-Hours: 20:00
Pfizer Net Income (Annual) : 7.787B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.787B |
| December 31, 2024 | 8.051B |
| December 31, 2023 | 2.172B |
| December 31, 2022 | 31.40B |
| December 31, 2021 | 22.46B |
| December 31, 2020 | 6.666B |
| December 31, 2019 | 10.87B |
| December 31, 2018 | 11.18B |
| December 31, 2017 | 21.35B |
| December 31, 2016 | 7.229B |
| December 31, 2015 | 6.975B |
| December 31, 2014 | 9.119B |
| December 31, 2013 | 11.41B |
| December 31, 2012 | 9.021B |
| December 31, 2011 | 7.86B |
| December 31, 2010 | 8.211B |
| December 31, 2009 | 8.63B |
| December 31, 2008 | 8.049B |
| December 31, 2007 | 8.255B |
| December 31, 2006 | 11.04B |
| December 31, 2005 | 7.622B |
| December 31, 2004 | 11.34B |
| December 31, 2003 | 1.642B |
| Date | Value |
|---|---|
| December 31, 2002 | 9.187B |
| December 31, 2001 | 7.768B |
| December 31, 2000 | 3.732B |
| December 31, 1999 | 3.204B |
| December 31, 1998 | 1.952B |
| December 31, 1997 | 2.223B |
| December 31, 1996 | 1.935B |
| December 31, 1995 | 1.561B |
| December 31, 1994 | 1.303B |
| December 31, 1993 | 660.10M |
| December 31, 1992 | 1.096B |
| December 31, 1991 | 725.30M |
| December 31, 1990 | 805.40M |
| December 31, 1989 | 685.20M |
| December 31, 1988 | 794.40M |
| December 31, 1987 | 693.50M |
| December 31, 1986 | 664.20M |
| December 31, 1985 | 585.00M |
| December 31, 1984 | 514.20M |
| December 31, 1983 | 452.90M |
| December 31, 1982 | 338.20M |
| December 31, 1981 | 279.40M |
| December 31, 1980 | 261.90M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Johnson & Johnson | 26.80B |
| Eli Lilly & Co. | 20.64B |
| Merck & Co., Inc. | 18.26B |
| Bristol Myers Squibb Co. | 7.056B |
| Viatris, Inc. | -3.515B |